Fresenius Group Overview


The Group’s maturity profile is characterized by a broad spread of maturities with a large proportion of mid- to long-term financing.

Debt maturity profile of the Fresenius Group

As of  December 31, 2016; based on utilization of major financing instruments
Pro forma Quirónsalud acquisition: €2.6 billion Senior Notes; €1.2 billion Senior Credit Agreement incremental facilities; €1.0 billion Schuldschein Loans, and €500 million equity-neutral convertible bonds